Shu YQ - Search Results

1

Restoration of gefitinib efficacy following chemotherapy in a patient with metastatic non-small cell lung cancer.

Li XD, Geng YT, Wu CP, Shen H, Sun J, Shu YQ, Yin YM. Li XD, et al. Among authors: shu yq. Onkologie. 2010;33(8-9):466-9. doi: 10.1159/000319109. Epub 2010 Jul 27. Onkologie. 2010. PMID: 20838064

2

Genomic alterations in lung adenocarcinomas detected by multicolor fluorescence in situ hybridization and comparative genomic hybridization.

Shen H, Zhu Y, Wu YJ, Qiu HR, Shu YQ. Shen H, et al. Among authors: shu yq. Cancer Genet Cytogenet. 2008 Mar;181(2):100-7. doi: 10.1016/j.cancergencyto.2007.11.012. Cancer Genet Cytogenet. 2008. PMID: 18295661

3

Multicolor fluorescence in situ hybridization and comparative genomic hybridization reveal molecular events in lung adenocarcinomas and squamous cell lung carcinomas.

Shen H, Gao W, Wu YJ, Qiu HR, Shu YQ. Shen H, et al. Among authors: shu yq. Biomed Pharmacother. 2009 Jul;63(6):396-403. doi: 10.1016/j.biopha.2008.08.010. Epub 2008 Sep 16. Biomed Pharmacother. 2009. PMID: 18848758

4

JNK/AP-1 pathway is involved in tumor necrosis factor-alpha induced expression of vascular endothelial growth factor in MCF7 cells.

Yin Y, Wang S, Sun Y, Matt Y, Colburn NH, Shu Y, Han X. Yin Y, et al. Biomed Pharmacother. 2009 Jul;63(6):429-35. doi: 10.1016/j.biopha.2009.04.045. Epub 2009 Jun 9. Biomed Pharmacother. 2009. PMID: 19553068 Free PMC article.

5

Gene expression of the invasive phenotype of TNF-alpha-treated MCF-7 cells.

Yin Y, Chen X, Shu Y. Yin Y, et al. Biomed Pharmacother. 2009 Jul;63(6):421-8. doi: 10.1016/j.biopha.2009.04.032. Epub 2009 Jun 13. Biomed Pharmacother. 2009. PMID: 19564093

6

CD13+CD4+CD25hi regulatory T cells exhibit higher suppressive function and increase with tumor stage in non-small cell lung cancer patients.

Ju S, Qiu H, Zhou X, Zhu B, Lv X, Huang X, Li J, Zhang Y, Liu L, Ge Y, Johnson DE, Ju S, Shu Y. Ju S, et al. Cell Cycle. 2009 Aug 15;8(16):2578-85. doi: 10.4161/cc.8.16.9302. Epub 2009 Aug 19. Cell Cycle. 2009. PMID: 19597336

7

Involvement of mTOR and survivin inhibition in tamoxifen-induced apoptosis in human hepatoblastoma cell line HepG2.

Guo R, Wang T, Shen H, Ge HM, Sun J, Huang ZH, Shu YQ. Guo R, et al. Among authors: shu yq. Biomed Pharmacother. 2010 Apr;64(4):249-53. doi: 10.1016/j.biopha.2009.06.007. Epub 2009 Oct 22. Biomed Pharmacother. 2010. PMID: 19931998

8

Combined tamoxifen and gefitinib in non-small cell lung cancer shows antiproliferative effects.

Shen H, Yuan Y, Sun J, Gao W, Shu YQ. Shen H, et al. Among authors: shu yq. Biomed Pharmacother. 2010 Feb;64(2):88-92. doi: 10.1016/j.biopha.2009.06.010. Epub 2009 Oct 23. Biomed Pharmacother. 2010. PMID: 20005069

9

A 3'-untranslated region polymorphism in IGF1 predicts survival of non-small cell lung cancer in a Chinese population.

Zhang M, Hu Z, Huang J, Shu Y, Dai J, Jin G, Tang R, Dong J, Chen Y, Xu L, Huang X, Shen H. Zhang M, et al. Clin Cancer Res. 2010 Feb 15;16(4):1236-44. doi: 10.1158/1078-0432.CCR-09-2719. Epub 2010 Feb 9. Clin Cancer Res. 2010. PMID: 20145156

10

Weekly paclitaxel/ docetaxel combined with a platinum in the treatment of advanced non-small cell lung cancer: a study on efficacy, safety and pre-medication.

Zhou JN, Huang XE, Ye Z, Li C, Zhang Q, Lin Y, Jiang W, Sunh WL, Shi MQ, Shu YQ. Zhou JN, et al. Among authors: shu yq. Asian Pac J Cancer Prev. 2009;10(6):1147-50. Asian Pac J Cancer Prev. 2009. PMID: 20192601 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

462 results

Search Page

Filters